Waiting
Traitement de la connexion…

Trial ends in Request Full Access Tell Your Colleague About Jove
Journal / Medicine / An Affordable HIV-1 Drug Resistance Monitoring…
JoVE Journal
Medicine
Author Produced

Ce contenu est en libre accès.

JoVE Journal Medicine
An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
 

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

Article DOI: 10.3791/51242-v • 19:57 min • March 30th, 2014
March 30th, 2014 •
1, 1, 1, 1, 1, 1, 1, 2, 3, 1, 4, 1
1Africa Centre for Health and Population Studies, College of Health Sciences, University of KwaZulu-Natal, Durban, South Africa, 2Unit D11, Jembi Health Systems, 3Academic Medical Center, Department of Global Health, Amsterdam Institute for Global Health and Development (AIGHD), University of Amsterdam, 4Division of Infectious Diseases and Geographic Medicine, Centre for AIDS Research, Stanford Medical School

Chapitres

résumé
Automatic Translation

Drug resistance testing for HIV-1 infected individuals failing antiretroviral therapy (ART) can guide future therapies and improve treatment outcomes. Optimizing individual and population health outcomes in high HIV prevalence but resource-limited settings will ultimately require affordable and accessible drug resistance genotyping and interpretation methods.

Tags

HIV-1 Drug Resistance Monitoring Affordable Method Resource Limited Settings Antiretroviral Therapy ART Programs Sub-Saharan Africa Drug Resistance Testing Genotyping Laboratory Infrastructure Data Management Open Access Genotypic Drug Resistance Monitoring Method Free Open Source Software Individual Patient Reports Amplification Rate Plasma Samples Viral Load Sensitivity United States Food And Drug Administration (FDA) Viroseq Genotyping Method
Read Article

Get cutting-edge science videos from JoVE sent straight to your inbox every month.

Waiting X
Simple Hit Counter